|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/417 | |||
| A61K 31/498 | |||
| A61P 17/06 |
| (11) | Patento numeris | 2501373 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10779906.6 |
| Europos patento paraiškos padavimo data | 2010-11-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-09-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-02-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/057184 |
| Data | 2010-11-18 |
| (87) | Numeris | WO 2011/075267 |
| Data | 2011-06-23 |
| (30) | Numeris | Data | Šalis |
| 621942 | 2009-11-19 | US |
| (72) |
DEJOVIN, Jack, A., US
|
| (73) |
Galderma Laboratories LP,
14501 North Freeway, Fort Worth, TX 76177,
US
|
| (54) | USE OF ALPHA 2 ADRENERGIC RECEPTOR AGONISTS FOR TREATING OR PREVENTING PSORIASIS |
| USE OF ALPHA 2 ADRENERGIC RECEPTOR AGONISTS FOR TREATING OR PREVENTING PSORIASIS |